Name (Synonyms) | Correlation | |
---|---|---|
drug1248 | Intravenous Immune Globulin Wiki | 1.00 |
drug2305 | Standard Medical Treatment Wiki | 1.00 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
The objective of this study is to look for the presence of SARS-CoV-2 in the semen of patients diagnosed with COVID+ based on RT-PCR analysis of nasopharyngeal swabs.
Description: The search for the SARS-CoV-2 virus in semen will be carried out by RT-PCR analysis with the RealStar kit developed by Altona Diagnostics. The extraction of the nucleic acid suitable for sperm uses the Pure MagNA technique (Diagnostics ROCHE). This is an extraction technique that has already been validated for HIV-type RNA viruses in semen. The biological samples will be analysed either during the study or bio-banked and analysed at the end of the study. Only semen samples from patients detected positive for SARS-CoV-2 by RT-PCR on nasopharyngeal swab will be analyzed.
Measure: Testing for the presence of COVID-19 (SARS-CoV-2 virus) in the semen Time: 48 hoursDescription: Patients who have been found to carry the SARS-CoV-2 virus in their semen will be recalled after one month to re-test for the virus. In case of a positive re-test, a new search will be scheduled and so on until a negative result is found.
Measure: Kinetics of SARS-CoV-2 virus presence in the semen Time: 1 month